Can tigecycline raise liver enzymes?
Yes. Tigecycline can cause liver enzyme abnormalities, including increases in aminotransferases (ALT/AST) and other markers of liver lab tests. These changes are listed among the drug’s possible adverse effects in clinical safety information and labeling summaries [1].
How common are liver enzyme abnormalities with tigecycline?
The frequency of elevated liver enzymes varies by patient population and the way safety data are reported in product information. Lab abnormalities can occur during treatment, and clinicians monitor liver-related labs when using tigecycline, especially in people who already have liver disease or who are taking other potentially hepatotoxic drugs [1].
What does “liver enzyme abnormalities” look like clinically?
For many patients, enzyme elevations are detected on routine blood tests without obvious symptoms. In some cases, patients may develop signs or symptoms of liver injury (for example, jaundice or fatigue), but that is less common than lab-only abnormalities. If symptoms develop or labs rise substantially, treatment decisions typically depend on the degree of elevation and overall clinical status [1].
Who is at higher risk?
Risk can be higher in patients with pre-existing hepatic impairment and in those receiving prolonged therapy or multiple medications that affect the liver. Monitoring is especially important when there is existing liver dysfunction or other risk factors for drug-related liver injury [1].
What should clinicians do if liver tests rise?
Product safety guidance generally supports checking and trending liver tests during tigecycline therapy and reassessing the regimen if abnormalities are found. The threshold for holding or stopping treatment is based on the magnitude of enzyme elevation and clinical context, such as symptoms of hepatitis or signs of worsening liver function [1].
Are there alternatives if liver enzymes are affected?
If tigecycline is the suspected cause, clinicians often consider alternative antibiotics based on the infection type, culture results, and susceptibility, along with the patient’s liver function. The best switch depends on what organism is being treated and how severe the liver lab changes are [1].
Sources
- Tigecycline adverse reactions and liver enzyme abnormalities (lab abnormalities) – safety/labeling summary